How can you find a finance partner for a precision radiosurgery treatment device when you’re a new entrant in the market? That was the challenge facing healthcare entrepreneur Amethyst Radiotherapy Group (ARG) when they acquired two specialist radiosurgery clinics in the UK in March 2020.
The machine in question is Leksell Gamma Knife Icon™ manufactured by Elekta. It provides precision treatments for brain tumours, functional disorders and abnormal conditions of the blood vessels, also known as lesions. This highly sophisticated equipment directs beams of radiation precisely to the lesion in the patient’s brain, sparing surrounding healthy tissue. This eliminates the side effects normally associated with radiotherapy while improving the patient’s quality of life after treatment.
Daniel Baines is UK Sales Director at Elekta, the Swedish manufacturer. ‘What is unique about Gamma Knife Icon is that it can treat a wide range of brain lesions without the patient needing brain surgery. So not just secondary brain tumours, but also lesions caused by conditions like trigeminal neuralgia. The precision and speed of the technology also reduces the number of treatment sessions needed.’
Today, there are only seven Gamma Knife Icon systems in the UK. The two sites operated by ARG (The Queen Square Radiosurgery Centre in London and the Thornbury Radiosurgery Centre in Sheffield) are the only centres in the UK with NHS England accreditation to treat all four tiers of brain lesions.